What is Biohaven's income tax?

Biohaven (BHVN) reported income tax of $272K in Q1 2026.

How has Biohaven's income tax changed year-over-year?

Biohaven's income tax decreased by 55.3% year-over-year, from $609K to $272K.

What is the long-term trend for Biohaven's income tax?

Over 2 years (2023 to 2025), Biohaven's income tax has grown at a 2.1% compound annual growth rate (CAGR), from -$1.38M to $1.44M.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Biohaven (BHVN) Income Tax — Quarterly & Annual

Screener

Income Tax at other companies

Eli LillyLLY

$2.15B+92.8%

Xenon PharmaceuticalsXENE

-$585K+6.5%

Vir Biotechnology, Inc.VIR

$179K+5.3%

Monte Rosa Therapeutics, Inc.GLUE

$208K-82.7%

Avalo TherapeuticsAVTX

$18K+12.5%

Immunovant, Inc.IMVT

$1.55M+921%

Segments

By segment

See full

Reportable Segment$272K-55.3%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.17B+41.2%

Enterprise value$2.18B+31.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Biohaven’s 10-Q, filed May 4, 2026.

Filed: May 4, 2026, 4:07 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001935979-26-000045

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Loss from operations	(130,428)	(221,561)
Other income, net	168	493
Loss before provision for income taxes	(130,260)	(221,068)
Provision for income taxes	272	609
Net loss	$(130,532)	$(221,677)
Net loss per share — basic and diluted	$(0.88)	$(2.17)
Weighted average common shares outstanding—basic and diluted	147,615,197	101,943,396
Comprehensive loss:

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Biohaven's income tax?: Biohaven (BHVN) reported income tax of $272K in Q1 2026.
How has Biohaven's income tax changed year-over-year?: Biohaven's income tax decreased by 55.3% year-over-year, from $609K to $272K.
What is the long-term trend for Biohaven's income tax?: Over 2 years (2023 to 2025), Biohaven's income tax has grown at a 2.1% compound annual growth rate (CAGR), from -$1.38M to $1.44M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.